Search Results - Dinesh K. Chatoth
- Showing 1 - 3 results of 3
-
1
-
2
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension by Smeeta Sinha, Sagar U. Nigwekar, Vincent Brandenburg, Lisa J. Gould, Thomas E. Serena, Sharon M. Moe, George R. Aronoff, Dinesh K. Chatoth, Jeffrey L. Hymes, Kevin J. Carroll, Gabriela Alperovich, L Keller, Joan Perelló, Alex Gold, Glenn M. Chertow
Published 2024Artigo -
3
SARS-CoV-2 in Spent Dialysate from Chronic Peritoneal Dialysis Patients with COVID-19 by Xiaoling Wang, Amrish U. Patel, Lela Tisdale, Zahin Haq, Xiaoling Ye, Rachel Lasky, Priscila Preciado, Xia Tao, Gabriela Ferreira Dias, Joshua E. Chao, Mohamad I. Hakim, Maggie Han, Ohnmar Thwin, Jochen G. Raimann, Dinesh K. Chatoth, Peter Kotanko, Nadja Grobe
Published 2020Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Surgery
2019-20 coronavirus outbreak
Alternative medicine
Anesthesia
Betacoronavirus
Calcification
Calciphylaxis
Coronavirus disease 2019 (COVID-19)
Critically ill
Dermatology
Dialysis
Disease
Double blind
Extracorporeal
Hemodialysis
Hemofiltration
Infectious disease (medical specialty)
Intensive care medicine
Open label
Outbreak
Pathology
Peritoneal dialysis
Placebo
Randomized controlled trial
Renal replacement therapy
Sars virus
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology